Literature DB >> 11438644

Mutational analysis of the Cy motif from p21 reveals sequence degeneracy and specificity for different cyclin-dependent kinases.

J A Wohlschlegel1, B T Dwyer, D Y Takeda, A Dutta.   

Abstract

Inhibitors, activators, and substrates of cyclin-dependent kinases (cdks) utilize a cyclin-binding sequence, known as a Cy or RXL motif, to bind directly to the cyclin subunit. Alanine scanning mutagenesis of the Cy motif of the cdk inhibitor p21 revealed that the conserved arginine or leucine (constituting the conserved RXL sequence) was important for p21's ability to inhibit cyclin E-cdk2 activity. Further analysis of mutant Cy motifs showed, however, that RXL was neither necessary nor sufficient for a functional cyclin-binding motif. Replacement of either of these two residues with small hydrophobic residues such as valine preserved p21's inhibitory activity on cyclin E-cdk2, while mutations in either polar or charged residues dramatically impaired p21's inhibitory activity. Expressing p21N with non-RXL Cy sequences inhibited growth of mammalian cells, providing in vivo confirmation that RXL was not necessary for a functional Cy motif. We also show that the variant Cy motifs identified in this study can effectively target substrates to cyclin-cdk complexes for phosphorylation, providing additional evidence that these non-RXL motifs are functional. Finally, binding studies using p21 Cy mutants demonstrated that the Cy motif was essential for the association of p21 with cyclin E-cdk2 but not with cyclin A-cdk2. Taking advantage of this differential specificity toward cyclin E versus cyclin A, we demonstrate that cell growth inhibition was absolutely dependent on the ability of a p21 derivative to inhibit cyclin E-cdk2.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11438644      PMCID: PMC87195          DOI: 10.1128/MCB.21.15.4868-4874.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  26 in total

1.  Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex.

Authors:  A A Russo; P D Jeffrey; A K Patten; J Massagué; N P Pavletich
Journal:  Nature       Date:  1996-07-25       Impact factor: 49.962

2.  Analysis of cell-cycle profiles in transfected cells using a membrane-targeted GFP.

Authors:  W Jiang; T Hunter
Journal:  Biotechniques       Date:  1998-03       Impact factor: 1.993

Review 3.  Cyclin-dependent kinases: engines, clocks, and microprocessors.

Authors:  D O Morgan
Journal:  Annu Rev Cell Dev Biol       Date:  1997       Impact factor: 13.827

4.  Tenascin-C hexabrachion assembly is a sequential two-step process initiated by coiled-coil alpha-helices.

Authors:  R A Kammerer; T Schulthess; R Landwehr; A Lustig; D Fischer; J Engel
Journal:  J Biol Chem       Date:  1998-04-24       Impact factor: 5.157

5.  p21CIP1 and Cdc25A: competition between an inhibitor and an activator of cyclin-dependent kinases.

Authors:  P Saha; Q Eichbaum; E D Silberman; B J Mayer; A Dutta
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

6.  Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors.

Authors:  P D Adams; W R Sellers; S K Sharma; A D Wu; C M Nalin; W G Kaelin
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

7.  Purification and analysis of CIP/KIP proteins.

Authors:  B D Dynlacht; C Ngwu; J Winston; E C Swindell; S J Elledge; E Harlow; J W Harper
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

8.  Human CDC6/Cdc18 associates with Orc1 and cyclin-cdk and is selectively eliminated from the nucleus at the onset of S phase.

Authors:  P Saha; J Chen; K C Thome; S J Lawlis; Z H Hou; M Hendricks; J D Parvin; A Dutta
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

9.  Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A.

Authors:  B A Schulman; D L Lindstrom; E Harlow
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

10.  Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex.

Authors:  P D Jeffrey; A A Russo; K Polyak; E Gibbs; J Hurwitz; J Massagué; N P Pavletich
Journal:  Nature       Date:  1995-07-27       Impact factor: 49.962

View more
  30 in total

1.  A cyclin-binding motif in human papillomavirus type 18 (HPV18) E1^E4 is necessary for association with CDK-cyclin complexes and G2/M cell cycle arrest of keratinocytes, but is not required for differentiation-dependent viral genome amplification or L1 capsid protein expression.

Authors:  Gillian L Knight; Alice G Pugh; Emma Yates; Ian Bell; Regina Wilson; Cary A Moody; Laimonis A Laimins; Sally Roberts
Journal:  Virology       Date:  2011-01-31       Impact factor: 3.616

2.  Interaction of the S-phase cyclin Clb5 with an "RXL" docking sequence in the initiator protein Orc6 provides an origin-localized replication control switch.

Authors:  Gwendolyn M Wilmes; Vincent Archambault; Richard J Austin; Matthew D Jacobson; Stephen P Bell; Frederick R Cross
Journal:  Genes Dev       Date:  2004-04-22       Impact factor: 11.361

3.  Reversal of growth suppression by p107 via direct phosphorylation by cyclin D1/cyclin-dependent kinase 4.

Authors:  Xiaohong Leng; Martin Noble; Peter D Adams; Jun Qin; J Wade Harper
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

4.  Ciz1 cooperates with cyclin-A-CDK2 to activate mammalian DNA replication in vitro.

Authors:  Nikki A Copeland; Heather E Sercombe; Justin F X Ainscough; Dawn Coverley
Journal:  J Cell Sci       Date:  2010-03-09       Impact factor: 5.285

5.  Among B-type cyclins only CLB5 and CLB6 promote premeiotic S phase in Saccharomyces cerevisiae.

Authors:  James M DeCesare; David T Stuart
Journal:  Genetics       Date:  2011-12-29       Impact factor: 4.562

6.  DNA replication of mitotic chromatin in Xenopus egg extracts.

Authors:  Tatyana A Prokhorova; Karen Mowrer; Catherine H Gilbert; Johannes C Walter
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

7.  Functional Analysis of Short Linear Motifs in the Plant Cyclin-Dependent Kinase Inhibitor SIAMESE.

Authors:  Narender Kumar; Renee Dale; Daniel Kemboi; Elizabeth A Zeringue; Naohiro Kato; John C Larkin
Journal:  Plant Physiol       Date:  2018-06-14       Impact factor: 8.340

8.  Mechanistic insights into avian reovirus p17-modulated suppression of cell cycle CDK-cyclin complexes and enhancement of p53 and cyclin H interaction.

Authors:  Hung-Chuan Chiu; Wei-Ru Huang; Tsai-Ling Liao; Pei-I Chi; Brent L Nielsen; Jyung-Hurng Liu; Hung-Jen Liu
Journal:  J Biol Chem       Date:  2018-06-15       Impact factor: 5.157

9.  Gauchos and ochos: a Wee1-Cdk tango regulating mitotic entry.

Authors:  Greg H Enders
Journal:  Cell Div       Date:  2010-05-13       Impact factor: 5.130

10.  Expression of geminin as a marker of cell proliferation in normal tissues and malignancies.

Authors:  James A Wohlschlegel; Jeffery L Kutok; Andrew P Weng; Anindya Dutta
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.